GSA Capital Partners’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$468K Buy
125,750
+42,956
+52% +$297K 0.03% 962
2025
Q4
$677K Buy
+82,794
New +$612K 0.06% 617
2023
Q1
Sell
-19,966
Closed -$129K 1719
2022
Q4
$129K Buy
19,966
+4,556
+30% +$37.5K 0.02% 1276
2022
Q3
$137K Buy
+15,410
New +$157K 0.02% 1313
2021
Q4
Sell
-40,153
Closed -$370K 1624
2021
Q3
$370K Buy
+40,153
New +$437K 0.04% 884
2021
Q1
Sell
-23,606
Closed -$256K 1301
2020
Q4
$256K Sell
23,606
-24,333
-51% -$251K 0.04% 828
2020
Q3
$466K Buy
47,939
+33,335
+228% +$317K 0.08% 439
2020
Q2
$116K Buy
+14,604
New +$151K 0.06% 456
2019
Q3
Sell
-13,129
Closed -$123K 1561
2019
Q2
$123K Buy
+13,129
New +$133K 0.01% 1321

Other funds holding LFCR